Qinglin Pei

Also affiliated with Neurobehavioral Systems, Children's Oncology Group, Florida College

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.208Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae013

Top 65%

0.208DataRank

Top 65%3 citations

Suzi Birz, Sharon M. Castellino, Tara O. Henderson, John T. Lucas, Qinglin Pei +36 more

Papers

Driven by 13 papers — median percentile 35. Top paper: “Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma”.

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma

New England Journal of Medicine(2022)10.1056/nejmoa2206660

N/A

3.7DataRank · unranked

170 citations

Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen M. McCarten, Terzah M. Horton +10 more

Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study

Journal of Patient-Reported Outcomes(2023)10.1186/s41687-023-00653-0

N/A

0.569DataRank · unranked

14 citations

Angie Mae Rodday, Qinglin Pei, Frank G. Keller, Yue Wu, Tara O. Henderson +4 more

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis

Blood(2022)10.1182/blood.2022016098

N/A

0.531DataRank · unranked

14 citations

Frank G. Keller, Kathleen M. McCarten, Sandy Kessel, Steve Cho, Qinglin Pei +8 more

Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.02.020

N/A

0.330DataRank · unranked

7 citations

Kathleen M. McCarten, Qinglin Pei, Sandy Kessel, Adina Alazraki, Joyce Mhlanga +12 more

Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae013

Top 65%

0.208DataRank

Top 65%3 citations

Suzi Birz, Sharon M. Castellino, Tara O. Henderson, John T. Lucas, Qinglin Pei +36 more

Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma

Blood Advances(2025)10.1182/bloodadvances.2025016797

N/A

0.208DataRank · unranked

3 citations

Lindsay A. Renfro, Hema Dave, G. Pezzella, Qinglin Pei, Lisa Giulino‐Roth +6 more

PET Response and Outcome in Low‐Risk Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1

Pediatric Blood & Cancer(2025)10.1002/pbc.31606

N/A

0DataRank · unranked

3 citations

Yue Wu, Kathleen M. McCarten, Lindsay A. Renfro, Qinglin Pei, Kara M. Kelly +4 more

Using Multi-Method Insights to Develop a Novel Chronic Pain Self-Management Intervention for Black Older Adults

Journal of Racial and Ethnic Health Disparities(2025)10.1007/s40615-025-02805-y

N/A

0DataRank · unranked

0 citations

Saif Al‐Zahid, Simone Jackson, Fatih Kunkul, Margaret Ayorinde, Fern J. Webb +9 more

Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7504

N/A

0DataRank · unranked

5 citations

Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen M. McCarten, Angela Punnett +9 more

Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study

British Journal of Haematology(2023)10.1111/bjh.18734

N/A

0DataRank · unranked

16 citations

Ji‐Hyun Kim, Qinglin Pei, Inki Lee, Bradford S. Hoppe, Yue Wu +9 more

PATTERNS OF PRESENTATION AND OUTCOMES IN STAGE IV HODGKIN LYMPHOMA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP (COG) AHOD1331 TRIAL

Hematological Oncology(2023)10.1002/hon.3163_34

N/A

0DataRank · unranked

1 citations

Kathleen M. McCarten, Qinglin Pei, Sarah A. Milgrom, Joseph L. Belsky, S. Cho +6 more

Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma

JCO Oncology Practice(2024)10.1200/op.24.00089

N/A

0DataRank · unranked

7 citations

Susan K. Parsons, Frank G. Keller, Lindsay A. Renfro, Qinglin Pei, Angie Mae Rodday +7 more

Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3876

N/A

0DataRank · unranked

6 citations

Raymond B. Mailhot Vega, Lindsay A. Renfro, Qinglin Pei, Anne-Marie Charpentier, Rahul R. Parikh +15 more

Qinglin Pei

Indexed papers

Top data-sharing exemplar

Papers